Sökning: onr:"swepub:oai:lup.lub.lu.se:bba07c02-b3a6-457f-b691-61417c54ca63" > Effects of DPP-4 in...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03857naa a2200481 4500 | |
001 | oai:lup.lub.lu.se:bba07c02-b3a6-457f-b691-61417c54ca63 | |
003 | SwePub | |
008 | 170120s2017 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/bba07c02-b3a6-457f-b691-61417c54ca632 URI |
024 | 7 | a https://doi.org/10.1111/dom.128172 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Yabe, Daisukeu Kobe university4 aut |
245 | 1 0 | a Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes : A randomized, open-label, 2-arm parallel comparative, exploratory trial |
264 | c 2016-11-29 | |
264 | 1 | b Wiley,c 2017 |
520 | a Dipeptidyl peptidase-4 (DPP-4) inhibitors reduce the risk of hypoglycaemia, possibly through augmentation of glucose-dependent insulinotropic polypeptide (GIP) action, but not that of glucagon-like peptide-1 (GLP-1) on glucagon secretion. To examine this model in Japanese individuals with type 2 diabetes (T2D), the effects of the DPP-4 inhibitor linagliptin on glucagon and other counter-regulatory hormone responses to hypoglycaemia were evaluated and compared with those of the GLP-1 receptor agonist liraglutide in a multi-centre, randomized, open-label, 2-arm parallel comparative, exploratory trial. Three-step hypoglycaemic clamp glucose tests preceded by meal tolerance tests were performed before and after 2-week treatment with the drugs. Glucagon levels were increased during the hypoglycaemic clamp test at 2.5mmol/L. This increase was similar in the linagliptin and liraglutide groups, both before and after the 2-week treatment. Changes in other counter-regulatory hormones (ie, growth hormone, cortisol, epinephrine and norepinephrine) were also similar between the groups, but were suppressed substantially after 2-week treatment compared to baseline. In conclusion, we confirmed that the glucagon response to hypoglycaemia was not affected by linagliptin or liraglutide treatment in Japanese individuals with T2D. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
653 | a GLP-1 receptor agonist | |
653 | a DPP-4 inhibitor | |
653 | a Glucagon response | |
653 | a Hypoglycaemia | |
653 | a Sympatho-adrenal response | |
700 | 1 | a Eto, Takashiu Hakata Clinic4 aut |
700 | 1 | a Shiramoto, Masanariu Hakata Clinic4 aut |
700 | 1 | a Irie, Shinu Hakata Clinic4 aut |
700 | 1 | a Murotani, Kentau Aichi Medical University4 aut |
700 | 1 | a Seino, Yusukeu Nagoya University4 aut |
700 | 1 | a Kuwata, Hitoshiu Kansai Electric Power Medical Research Institute (KEPMRI)4 aut |
700 | 1 | a Kurose, Takeshiu Kansai Electric Power Medical Research Institute (KEPMRI)4 aut |
700 | 1 | a Seino, Susumuu Kobe university4 aut |
700 | 1 | a Ahrén, Bou Lund University,Lunds universitet,Medicin, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)med-bah |
700 | 1 | a Seino, Yutakau Kansai Electric Power Medical Research Institute (KEPMRI)4 aut |
710 | 2 | a Kobe universityb Hakata Clinic4 org |
773 | 0 | t Diabetes, Obesity and Metabolismd : Wileyg 19:3, s. 442-447q 19:3<442-447x 1462-8902 |
856 | 4 | u http://dx.doi.org/10.1111/dom.12817x freey FULLTEXT |
856 | 4 | u https://doi.org/10.1111/dom.12817 |
856 | 4 8 | u https://lup.lub.lu.se/record/bba07c02-b3a6-457f-b691-61417c54ca63 |
856 | 4 8 | u https://doi.org/10.1111/dom.12817 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy